Given the downregulation of Aldh1a1 that we observe in early synucleinopathy and potential loss of a protective enzyme, DOPAL accumulation and toxicity are mechanisms which could contribute to synucleinopathy progression and should be examined in future studies. The gene discussed is ALDH1A1; the disease is synucleinopathy.